Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8235449rdf:typepubmed:Citationlld:pubmed
pubmed-article:8235449lifeskim:mentionsumls-concept:C0035366lld:lifeskim
pubmed-article:8235449lifeskim:mentionsumls-concept:C1513846lld:lifeskim
pubmed-article:8235449lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:8235449lifeskim:mentionsumls-concept:C0004368lld:lifeskim
pubmed-article:8235449lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8235449lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8235449pubmed:issue5lld:pubmed
pubmed-article:8235449pubmed:dateCreated1993-12-9lld:pubmed
pubmed-article:8235449pubmed:abstractTextPolyclonal activation of B-lymphocytes accompanies many retroviral infections. Friend derived murine immunosuppressive virus (Fd-MIV) is a non-defective murine retrovirus which was isolated from T-helper cells from mice infected with the acute transforming retrovirus Friend leukaemia complex (FLC). In contrast to FLC, Fd-MIV does not induce acute transformation of lymphoid and erythroid cells but causes immunosuppression and lymphadenopathy in adult NMRI mice. The effect of Fd-MIV infection on B-lymphocytes was studied. Fd-MIV infection led to a persistent hypergammaglobulinemy with a significant increase in the level of circulating IgG, IgM and immune complexes. In the spleen and lymph nodes, B-lymphocyte proliferation was found. Parallel to the development of hypergammaglobulinemy, autoantibodies to a variety of nuclear and other autoantigens was detected. In conclusion, the Fd-MIV infection leads to a B-lymphocyte dysfunction that has many parallels with AIDS. Furthermore, the Fd-MIV infection seems to represent an example of an autoimmune condition caused by an exogenous infectious agent.lld:pubmed
pubmed-article:8235449pubmed:languageenglld:pubmed
pubmed-article:8235449pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8235449pubmed:citationSubsetIMlld:pubmed
pubmed-article:8235449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8235449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8235449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8235449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8235449pubmed:statusMEDLINElld:pubmed
pubmed-article:8235449pubmed:monthNovlld:pubmed
pubmed-article:8235449pubmed:issn0300-9475lld:pubmed
pubmed-article:8235449pubmed:authorpubmed-author:DalenA BABlld:pubmed
pubmed-article:8235449pubmed:authorpubmed-author:MoenTTlld:pubmed
pubmed-article:8235449pubmed:authorpubmed-author:FaxvaagAAlld:pubmed
pubmed-article:8235449pubmed:issnTypePrintlld:pubmed
pubmed-article:8235449pubmed:volume38lld:pubmed
pubmed-article:8235449pubmed:ownerNLMlld:pubmed
pubmed-article:8235449pubmed:authorsCompleteYlld:pubmed
pubmed-article:8235449pubmed:pagination459-62lld:pubmed
pubmed-article:8235449pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:meshHeadingpubmed-meshheading:8235449-...lld:pubmed
pubmed-article:8235449pubmed:year1993lld:pubmed
pubmed-article:8235449pubmed:articleTitlePolyclonal activation of B-lymphocytes and induction of autoimmunity in retrovirus infected NMRI mice.lld:pubmed
pubmed-article:8235449pubmed:affiliationInstitute of Cancer Research, University of Trondheim, Norway.lld:pubmed
pubmed-article:8235449pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8235449lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8235449lld:pubmed